218 related articles for article (PubMed ID: 9603172)
1. Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine.
Casteels K; Waer M; Laureys J; Valckx D; Depovere J; Bouillon R; Mathieu C
Transplantation; 1998 May; 65(9):1225-32. PubMed ID: 9603172
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with cyclosporine and interleukin-4 or interleukin-10 prolongs survival of synergeneic pancreatic islet grafts in nonobese diabetic mice: islet graft survival does not correlate with mRNA levels of type 1 or type 2 cytokines, or transforming growth factor-beta in the islet grafts.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
Transplantation; 1997 Dec; 64(11):1525-31. PubMed ID: 9415551
[TBL] [Abstract][Full Text] [Related]
3. Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3.
Gysemans C; Van Etten E; Overbergh L; Verstuyf A; Waer M; Bouillon R; Mathieu C
Clin Exp Immunol; 2002 May; 128(2):213-20. PubMed ID: 11985511
[TBL] [Abstract][Full Text] [Related]
4. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
[TBL] [Abstract][Full Text] [Related]
5. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
J Immunol; 1997 Dec; 159(12):6298-303. PubMed ID: 9550435
[TBL] [Abstract][Full Text] [Related]
6. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
[TBL] [Abstract][Full Text] [Related]
7. Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice. Analysis of cytokine mRNA expression in the graft.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF; Rajotte RV
Transplantation; 1995 Aug; 60(4):368-74. PubMed ID: 7652767
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppression preventing concordant xenogeneic islet graft rejection is not sufficient to prevent recurrence of autoimmune diabetes in nonobese diabetic mice.
Guo Z; Mital D; Shen J; Chong AS; Tian Y; Foster P; Sankary H; McChesney L; Jensik SC; Williams JW
Transplantation; 1998 May; 65(10):1310-4. PubMed ID: 9625011
[TBL] [Abstract][Full Text] [Related]
9. Prevention of autoimmune destruction of transplanted islets in spontaneously diabetic NOD mice by KH1060, a 20-epi analog of vitamin D: synergy with cyclosporine.
Mathieu C; Laureys J; Waer M; Bouillon R
Transplant Proc; 1994 Dec; 26(6):3128-9. PubMed ID: 7998092
[No Abstract] [Full Text] [Related]
10. Combination therapy with epidermal growth factor and gastrin delays autoimmune diabetes recurrence in nonobese diabetic mice transplanted with syngeneic islets.
Suarez-Pinzon WL; Rabinovitch A
Transplant Proc; 2008 Mar; 40(2):529-32. PubMed ID: 18374121
[TBL] [Abstract][Full Text] [Related]
11. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
[TBL] [Abstract][Full Text] [Related]
13. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.
Lakey JR; Singh B; Warnock GL; Rajotte RV
Transplantation; 1994 Apr; 57(8):1213-7. PubMed ID: 8178349
[TBL] [Abstract][Full Text] [Related]
14. Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction.
Suarez-Pinzon WL; Marcoux Y; Ghahary A; Rabinovitch A
Cell Transplant; 2002; 11(6):519-28. PubMed ID: 12428741
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice.
Smith DK; Korbutt GS; Suarez-Pinzon WL; Kao D; Rajotte RV; Elliott JF
Transplantation; 1997 Oct; 64(7):1040-9. PubMed ID: 9381527
[TBL] [Abstract][Full Text] [Related]
16. The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation.
Yang Z; Chen M; Ellett JD; Fialkow LB; Carter JD; Nadler JL
Transplantation; 2004 Jan; 77(1):55-60. PubMed ID: 14724435
[TBL] [Abstract][Full Text] [Related]
17. Primary nonfunction of islet grafts in autoimmune diabetic nonobese diabetic mice is prevented by treatment with interleukin-4 and interleukin-10.
Faust A; Rothe H; Schade U; Lampeter E; Kolb H
Transplantation; 1996 Sep; 62(5):648-52. PubMed ID: 8830831
[TBL] [Abstract][Full Text] [Related]
18. Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720.
Fu F; Hu S; Deleo J; Li S; Hopf C; Hoover J; Wang S; Brinkmann V; Lake P; Shi VC
Transplantation; 2002 May; 73(9):1425-30. PubMed ID: 12023620
[TBL] [Abstract][Full Text] [Related]
19. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression.
Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanaga M; Ko S; Nagao M; Nakajima Y
Transplantation; 2003 Mar; 75(5):619-25. PubMed ID: 12640299
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
